Elevated adiponectin levels in patients with chronic heart failure: An independent predictor of mortality or a marker of cardiac cachexia?

International Journal of Cardiology

Volumn 144, Issue 2, 2010, Pages 319-320

  Celik, Turgay ^a   Yaman, Halil ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adiponectin; Heart failure; Prognosis

Indexed keywords

ADIPONECTIN;

BODY MASS; CACHEXIA; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; LETTER; MORTALITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYSTOLIC DYSFUNCTION;

EID: 77957836372     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.006     Document Type: Article

References (9)

1. I.D. Laoutaris, I.K. Vasiliadis, and A. Dritsas High plasma adiponectin is related to low functional capacity in patients with chronic heart failure Int J Cardiol Jan 26 2009 [Electronic publication ahead of print]
2. C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
3. J. George, S. Patal, and D. Wexler Circulating adiponectin concentrations in patients with congestive heart failure Heart 92 2006 1420 1424
4. T.B. Horwich, G.C. Fonarow, M.A. Hamilton, W.R. MacLellan, M.A. Woo, and J.H. Tillisch The relationship between obesity and mortality in patients with heart failure J Am Coll Cardiol 38 2001 789 795
5. S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
6. T. Tsutamoto, T. Tanaka, and H. Sakai Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure Eur Heart J 28 2007 1723 1730
7. S.D. Anker, A. Negassa, and A.J. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
8. S. Kenchaiah, S.J. Pocock, and D. Wang CHARM Investigators. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 116 2007 627 636
9. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150